2m 2m 2m 2m 2m 2m 2m
DESIGN THERAP (DSGN)
NASDAQ
$12.17-$0.010 (-0.08%)
Price as of Aug 03, 2026 6:38 AM EDT- $760.7MMarket Cap
- 218.85%1-Year Change
- BiotechnologyIndustry
DESIGN THERAP (DSGN)
$12.17-$0.010 (-0.08%)
DSGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.18 | ||
Change | -$0.44 (-3.49%) | ||
Open | $12.62 | ||
High | $13.36 | ||
Low | $12.06 | ||
Previous Close | $12.62 | ||
Volume | 628,264 | ||
30-Day Average Volume | 685,391 | ||
1-Week Change | 3.40% | ||
1-Month Change | -15.83% | ||
1-Year Change | 218.85% | ||
3-Year Change | 49.63% | ||
5-Year Change | -21.32% | ||
Fundamentals | |||
Shares Outstanding | 62.5M | ||
Total Assets | $230.4M | ||
Market Cap | $760.7M | ||
Enterprise Value | $748.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$17.6M | ||
Free Cash Flow | -$16.4M | ||
EBIT | -$17.6M | ||
EBITDA | -$17.5M | ||
Net Working Capital | $216.9M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -42 | ||
PEG | 7 | ||
Price/Free Cash Flow | -46 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue